Identification of Adiponectin Receptor Agonist Utilizing a Fluorescence Polarization Based High Throughput Assay

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Sun, Yiyi ^a   Zang, Zhihe ^a   Zhong, Ling ^a   Wu, Min ^a   Su, Qing ^a   Gao, Xiurong ^a   Zan, Wang ^a   Lin, Dong ^b   Zhao, Yan ^a   Zhang, Zhonglin ^a  

^a CHENGDU MEDICAL COLLEGE   (China)

^b Chengdu Lang Guan Technology Co Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 1 AGONIST; ADIPONECTIN RECEPTOR 2 AGONIST; ADIPONECTIN RECEPTOR AGONIST; ARCTIGENIN; ARCTIIN; DEOXYSCHIZANDRIN; GRAMINE; HORMONE RECEPTOR STIMULATING AGENT; LIGAND; MATAIRESINOL; PARTHENOLIDE; SYRINGIN; TAXIFOLIOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; FLUORESCENCE POLARIZATION; HIGH THROUGHPUT SCREENING; HORMONE DEFICIENCY; HUMAN; HUMAN CELL; IC 50; NONHUMAN; SIGNAL TRANSDUCTION; VALIDATION PROCESS;

BIOLOGICAL PRODUCTS; CELL PROLIFERATION; DRUG EVALUATION, PRECLINICAL; FLUORESCENCE POLARIZATION; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MCF-7 CELLS; RECEPTORS, ADIPONECTIN; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION;

EID: 84877771919     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063354     Document Type: Article

References (38)

1. Dalamaga M, Diakopoulos KN, Mantzoros CS (2012) The Role of Adiponectin in Cancer: A Review of Current Evidence. Endocr Rev.
2. Sun Y, Xun K, Wang C, Zhao H, Bi H, et al. (2009) Adiponectin, an unlocking adipocytokine. Cardiovascular therapeutics 27: 59-75.
3. Delaigle AM, Jonas JC, Bauche IB, Cornu O, Brichard SM, (2004) Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. Endocrinology 145: 5589-5597.
4. Kaser S, Moschen A, Cayon A, Kaser A, Crespo J, et al. (2005) Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut 54: 117-121.
5. Fayad R, Pini M, Sennello JA, Cabay RJ, Chan L, et al. (2007) Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology 132: 601-614.
6. Pineiro R, Iglesias MJ, Gallego R, Raghay K, Eiras S, et al. (2005) Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett 579: 5163-5169.
7. Katsiougiannis S, Kapsogeorgou EK, Manoussakis MN, Skopouli FN, (2006) Salivary gland epithelial cells: a new source of the immunoregulatory hormone adiponectin. Arthritis Rheum 54: 2295-2299.
8. Brochu-Gaudreau K, Rehfeldt C, Blouin R, Bordignon V, Murphy BD, et al. (2010) Adiponectin action from head to toe. Endocrine 37: 11-32.
9. Kadowaki T, Yamauchi T, (2005) Adiponectin and adiponectin receptors. Endocr Rev 26: 439-451.
10. Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, et al. (2007) Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13: 332-339.
11. Tsuchida A, Yamauchi T, Ito Y, Hada Y, Maki T, et al. (2004) Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 279: 30817-30822.
12. Dieudonne MN, Bussiere M, Dos Santos E, Leneveu MC, Giudicelli Y, et al. (2006) Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 345: 271-279.
13. Mao X, Kikani CK, Riojas RA, Langlais P, Wang L, et al. (2006) APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol 8: 516-523.
14. Dos Santos E, Benaitreau D, Dieudonne MN, Leneveu MC, Serazin V, et al. (2008) Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells. Oncol Rep 20: 971-977.
15. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, et al. (2000) Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102: 1296-1301.
16. Barb D, Williams CJ, Neuwirth AK, Mantzoros CS, (2007) Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr 86: s858-866.
17. Ziemke F, Mantzoros CS, (2010) Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 91: 258S-261S.
18. Sun Y, Chen X, (2010) Effect of adiponectin on apoptosis: proapoptosis or antiapoptosis? BioFactors 36: 179-186.
19. Kelesidis I, Kelesidis T, Mantzoros CS, (2006) Adiponectin and cancer: a systematic review. Br J Cancer 94: 1221-1225.
20. Hivert MF, Sullivan LM, Fox CS, Nathan DM, D'Agostino RB Sr, et al. (2008) Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab 93: 3165-3172.
21. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935.
22. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599.
23. Otvos L Jr, Haspinger E, La Russa F, Maspero F, Graziano P, et al. (2011) Design and development of a peptide-based adiponectin receptor agonist for cancer treatment. BMC Biotechnol 11: 90.
24. Sun Y, Xun K, Wang Y, Chen X, (2009) A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anti-cancer drugs 20: 757-769.
25. Sun Y, Zang Z, Xu X, Zhang Z, Zhong L, et al. (2011) Experimental investigation of the immunoregulatory and anti-inflammatory effects of the traditional Chinese medicine "Li-Yan Zhi-Ke Granule" for relieving chronic pharyngitis in rats. Molecular biology reports 38: 199-203.
26. Pfeiler GH, Buechler C, Neumeier M, Schaffler A, Schmitz G, et al. (2008) Adiponectin effects on human breast cancer cells are dependent on 17-beta estradiol. Oncol Rep 19: 787-793.
27. Nkhata KJ, Ray A, Schuster TF, Grossmann ME, Cleary MP, (2009) Effects of adiponectin and leptin co-treatment on human breast cancer cell growth. Oncol Rep 21: 1611-1619.
28. Grossmann ME, Nkhata KJ, Mizuno NK, Ray A, Cleary MP, (2008) Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer 98: 370-379.
29. Kang K, Lee HJ, Kim CY, Lee SB, Tunsag J, et al. (2007) The chemopreventive effects of Saussurea salicifolia through induction of apoptosis and phase II detoxification enzyme. Biol Pharm Bull 30: 2352-2359.
30. Shoeb M, MacManus SM, Kumarasamy Y, Jaspars M, Nahar L, et al. (2006) Americanin, a bioactive dibenzylbutyrolactone lignan, from the seeds of Centaurea americana. Phytochemistry 67: 2370-2375.
31. Opletal L, Sovova H, Bartlova M, (2004) Dibenzo[a,c]cyclooctadiene lignans of the genus Schisandra: importance, isolation and determination. Journal of chromatography B, Analytical technologies in the biomedical and life sciences 812: 357-371.
32. Liu KY, Wu YC, Liu IM, Yu WC, Cheng JT, (2008) Release of acetylcholine by syringin, an active principle of Eleutherococcus senticosus, to raise insulin secretion in Wistar rats. Neurosci Lett 434: 195-199.
33. Niu HS, Liu IM, Cheng JT, Lin CL, Hsu FL, (2008) Hypoglycemic effect of syringin from Eleutherococcus senticosus in streptozotocin-induced diabetic rats. Planta Med 74: 109-113.
34. Song YY, Li Y, Zhang HQ, (2010) [Therapeutic effect of syringin on adjuvant arthritis in rats and its mechanisms]. Yao Xue Xue Bao 45: 1006-1011.
35. D'Anneo A, Carlisi D, Lauricella M, Emanuele S, Di Fiore R,et al. (2012) Parthenolide induces caspase-independent and AIF-mediated cell death in human osteosarcoma and melanoma cells. J Cell Physiol.
36. Kim SL, Trang KT, Kim SH, Kim IH, Lee SO,et al. (2012) Parthenolide suppresses tumor growth in a xenograft model of colorectal cancer cells by inducing mitochondrial dysfunction and apoptosis. Int J Oncol.
37. Hong Y, Hu HY, Xie X, Sakoda A, Sagehashi M, et al. (2009) Gramine-induced growth inhibition, oxidative damage and antioxidant responses in freshwater cyanobacterium Microcystis aeruginosa. Aquat Toxicol 91: 262-269.
38. Ke S, Shi L, Cao X, Yang Q, Liang Y, et al. (2012) Heterocycle-functional gramine analogues: Solvent- and catalyst-free synthesis and their inhibition activities against cell proliferation. Eur J Med Chem 54: 248-254.